The Foot & Ankle Consolidation Trend Continues

kshepherd72
May 19, 2022
1 min read

On May 4, CONMED Corporation (NYSE: CNMD) announced a definitive agreement to acquire privately-held In2Bones Global, Inc. for cash consideration of $145 million at closing and up to an additional $110 million in growth-based earnout payments over a four-year period.

In2Bone, led by foot and ankle veteran Alan Taylor, had 2021 revenue of $36.8 million with sustained double-digit growth. While CONMED is a large company, including 3,500 employees, it has a small footprint in foot and ankle, making this a partnership an upside on both sides.

Recent Posts

See All

Denying the Denials: AI in Pre-Authorizations

The insurance side of AI Centers for Medicare and Medicaid Services (CMS) does not require insurers to disclose how they make authorization decisions or how predictive technologies factor into the p

Peripheral Nerve Blocks (PNBs) and Post-Op Pain: Help or Harm?

by Vince Vacketta, DPM PNBs have become a popular tool for managing pain after orthopedic surgery, but a new look at nearly 23,000 patients at Massachusetts General Hospital suggests the story is mo

Ligament Augmentation in Lateral Ankle

Ligament augmentation in lateral ankle reconstructions got a big boost with the publication of a Level 1 paper showing superior two- and five-year outcomes when using a ligament augment. Since then,

Comments